酒精滥用对阿尔茨海默病发病机制雏探
A Preliminary Study on the Mechanism of Alcohol Abuse in Alzheimer’s Disease
DOI: 10.12677/OJNS.2023.112017, PDF,    科研立项经费支持
作者: 徐加伟*, 车土玲, 蓝 萍:宁德师范学院医学院,福建 宁德;苏裕盛#:宁德师范学院医学院,福建 宁德;宁德师范学院毒物与药物毒理学重点实验室,福建 宁德
关键词: 阿尔茨海默酒精氧化应激炎症Alzheimer’s Disease Alcohol Oxidative Stress Inflammation
摘要: 阿尔茨海默病(Alzheimer disease, AD)是一种神经退行性疾病,主要表现为认知障碍。酒作为日常饮品虽能给人体带来益处,但过度饮酒将损害机体健康,目前研究成果展示由于酒精滥用会增加患AD的风险。为了探讨酒精对AD的作用机制,本文将通过AD的发病机制与酒精滥用对机体产生的危害进一步阐明酒精滥用对AD的影响。结果显示,酒精滥用将会导致机体产生炎症和氧化应激,而氧化应激又将进一步加重机体的炎症反应。此外,酒精滥用还会危害人体肠道微生物的数量及比例分布等,进而导致微生物生态失衡,不仅如此,肠道微生物还因酒精滥用导致炎症,这也将进一步危害机体的健康。又因氧化应激、炎症反应等又会加快AD的发病,所以由酒精滥用引起的氧化应激、炎症反应、肠道微生物失调等因素也能促进AD的发展。因此,控制酒精的摄取可能会在一定程度上减缓AD的发病,起到预防AD的作用。
Abstract: Alzheimer disease (AD) is a neurodegenerative disease, mainly manifested as cognitive impairment. Although alcohol as a daily drink can bring benefits to the human body, excessive drinking will damage the health of the body. The current research results show that alcohol abuse will increase the risk of AD. In order to explore the action mechanism of alcohol on AD, this article will further clarify the impact of alcohol abuse on AD through the pathogenesis of AD and the harm of alcohol abuse on the body. The results show that alcohol abuse will lead to inflammation and oxidative stress in the body, and oxidative stress will further aggravate the inflammatory reaction of the body. In addition, alcohol abuse will also harm the number and proportion of human intestinal microorganisms, which will lead to the imbalance of microbial ecology. In addition, intestinal microorganisms will also cause inflammation due to alcohol abuse, which will further endanger the health of the body. Because oxidative stress and inflammatory reaction will accelerate the onset of AD, factors such as oxidative stress, inflammatory reaction and intestinal microbial imbalance caused by alcohol abuse can also promote the development of AD. Therefore, controlling alcohol intake may slow down the onset of AD to a certain extent and play a role in preventing AD.
文章引用:徐加伟, 车土玲, 蓝萍, 苏裕盛. 酒精滥用对阿尔茨海默病发病机制雏探[J]. 自然科学, 2023, 11(2): 147-155. https://doi.org/10.12677/OJNS.2023.112017

参考文献

[1] ADI (2023) Dementia Facts & Figures. https://www.alzint.org/about/dementia-facts-figures
[2] Weller, J. and Budson, A. (2018) Current Understanding of Alzheimer’s Disease Diagnosis and Treatment. F1000Research, 7, 1161. [Google Scholar] [CrossRef] [PubMed]
[3] Chiti, F. and Dobson, C.M. (2017) Protein Mis-folding, Amyloid Formation, and Human Disease: A Summary of Progress over the Last Decade. Annual Review of Biochemistry, 86, 27-68. [Google Scholar] [CrossRef] [PubMed]
[4] Bishehsari, F., Magno, E., Swanson, G., et al. (2017) Alcohol and Gut-Derived Inflammation. Alcohol Research, 38, 163-171.
[5] Crews, F.T. (2008) Alco-hol-Related Neurodegeneration and Recovery: Mechanisms from Animal Models. Alcohol Research & Health, 31, 377-388.
[6] León, B.E., Kang, S., Franca-Solomon, G., et al. (2021) Alcohol-Induced Neuroinflammatory Re-sponse and Mitochondrial Dysfunction on Aging and Alzheimer’s Disease. Frontiers in Behavioral Neuroscience, 15, Article ID: 778456. [Google Scholar] [CrossRef] [PubMed]
[7] Peng, B., Yang, Q., et al. (2020) Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences, 21, 2316. [Google Scholar] [CrossRef] [PubMed]
[8] Crews, L. and Masliah, E. (2010) Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease. Human Molecular Genetics, 19, R12-R20. [Google Scholar] [CrossRef] [PubMed]
[9] Huang, Y.R. and Liu, R.T. (2020) The Toxicity and Polymorphism of beta-Amyloid Oligomers. International Journal of Molecular Sciences, 21, 4477. [Google Scholar] [CrossRef] [PubMed]
[10] Selkoe, D.J. and Hardy, J. (2016) The Amyloid Hypothesis of Alzheimer’s Disease at 25 Years. EMBO Molecular Medicine, 8, 595-608. [Google Scholar] [CrossRef] [PubMed]
[11] Gulisano, W., Maugeri, D., Baltrons, M.A., et al. (2018) Role of Amyloid-beta and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade. Journal of Alzheimer’s Disease, 64, S611-S631. [Google Scholar] [CrossRef
[12] Morris, G.P., Clark, I.A. and Vissel, B. (2014) Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer’s Disease. Acta Neuropathologica Communica-tions, 2, 135. [Google Scholar] [CrossRef] [PubMed]
[13] Albayram, O., Herbert, M.K., Kondo, A., et al. (2016) Function and Regulation of Tau Conformations in the Development and Treatment of Traumatic Brain Injury and Neurodegeneration. Cell & Bioscience, 6, 59. [Google Scholar] [CrossRef] [PubMed]
[14] Mandelkow, E.M. and Mandelkow, E. (2012) Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration. Cold Spring Harbor Perspectives in Medicine, 2, a6247. [Google Scholar] [CrossRef] [PubMed]
[15] Mashal, Y., Abdelhady, H. and Iyer, A.K. (2022) Comparison of Tau and Amyloid-beta Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease. Biomole-cules, 12, 1001. [Google Scholar] [CrossRef] [PubMed]
[16] Illenberger, S., Zheng-Fischhofer, Q., Preuss, U., et al. (1998) The Endogenous and Cell Cycle-Dependent Phosphorylation of Tau Protein in Living Cells: Implica-tions for Alzheimer’s Disease. Molecular Biology of the Cell, 9, 1495-1512. [Google Scholar] [CrossRef] [PubMed]
[17] la Joie, R., Visani, A.V., Baker, S.L., et al. (2020) Prospective Longitudinal Atrophy in Alzheimer’s Disease Correlates with the Intensity and Topography of Baseline tau-PET. Science Translational Medicine, 12, 524. [Google Scholar] [CrossRef] [PubMed]
[18] Mroczko, B., Groblewska, M. and Litman-Zawadzka, A. (2019) The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD). International Journal of Molecular Sciences, 20, 4661. [Google Scholar] [CrossRef] [PubMed]
[19] Ando, K., Oka, M., Ohtake, Y., et al. (2016) Tau Phosphorylation at Alzheimer’s Disease-Related Ser356 Contributes to Tau Stabilization When PAR-1/MARK Activity Is Elevated. Biochemical and Biophysical Research Communications, 478, 929-934. [Google Scholar] [CrossRef] [PubMed]
[20] Huang, F., Wang, M., Liu, R., et al. (2019) CDT2-Controlled Cell Cycle Reentry Regulates the Pathogenesis of Alzheimer’s Disease. Alzheimer’s & Dementia, 15, 217-231. [Google Scholar] [CrossRef] [PubMed]
[21] Lippai, D., Bala, S., Petrasek, J., et al. (2013) Alcohol-Induced IL-1beta in the Brain Is Mediated by NLRP3/ASC Inflammasome Activation That Amplifies Neuroinflammation. Journal of Leukocyte Biology, 94, 171-182. [Google Scholar] [CrossRef] [PubMed]
[22] Khan, S., Barve, K.H. and Kumar, M.S. (2020) Recent Advance-ments in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease. Current Neuropharmacology, 18, 1106-1125. [Google Scholar] [CrossRef
[23] Heneka, M.T., Carson, M.J., El, K.J., et al. (2015) Neuroinflammation in Alzheimer’s Disease. The Lancet Neurology, 14, 388-405. [Google Scholar] [CrossRef
[24] Cai, Z., Hussain, M.D. and Yan, L.J. (2014) Microglia, Neuroinflammation, and Beta-Amyloid Protein in Alzheimer’s Disease. International Journal of Neuroscience, 124, 307-321. [Google Scholar] [CrossRef] [PubMed]
[25] Doens, D. and Fernandez, P.L. (2014) Micro-glia Receptors and Their Implications in the Response to Amyloid Beta for Alzheimer’s Disease Pathogenesis. Journal of Neuroinflammation, 11, 48. [Google Scholar] [CrossRef] [PubMed]
[26] Gundersen, V., Storm-Mathisen, J. and Bergersen, L.H. (2015) Neuroglial Transmission. Physiological Reviews, 95, 695-726. [Google Scholar] [CrossRef] [PubMed]
[27] Steardo, L.J., Bronzuoli, M.R., Iacomino, A., et al. (2015) Does Neuroinflammation Turn on the Flame in Alzheimer’s Disease? Focus on Astrocytes. Frontiers in Neurosci-ence, 9, 259. [Google Scholar] [CrossRef] [PubMed]
[28] Gonzalez-Reimers, E., Santolaria-Fernandez, F., Martin-Gonzalez, M.C., et al. (2014) Alcoholism: A Systemic Proinflammatory Condition. World Journal of Gas-troenterology, 20, 14660-14671. [Google Scholar] [CrossRef] [PubMed]
[29] Erickson, E.K., Grantham, E.K., Warden, A.S., et al. (2019) Neuroimmune Signaling in Alcohol Use Disorder. Pharmacology Biochemistry and Behavior, 177, 34-60. [Google Scholar] [CrossRef] [PubMed]
[30] Liddelow, S.A., Guttenplan, K.A., Clarke, L.E., et al. (2017) Neurotoxic Reactive Astrocytes Are Induced by Activated Microglia. Nature, 541, 481-487. [Google Scholar] [CrossRef] [PubMed]
[31] Neupane, S.P. (2016) Neuroimmune Interface in the Comorbidity between Alcohol Use Disorder and Major Depression. Frontiers in Immunology, 7, 655. [Google Scholar] [CrossRef] [PubMed]
[32] Qin, L. and Crews, F.T. (2012) NADPH Oxidase and Reactive Oxygen Species Contribute to Alcohol-Induced Microglial Activation and Neurodegeneration. Journal of Neuroin-flammation, 9, 5. [Google Scholar] [CrossRef] [PubMed]
[33] Zhang, Y., Chen, K., Sloan, S.A., et al. (2014) An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex. Journal of Neuroscience, 34, 11929-11947. [Google Scholar] [CrossRef
[34] Kawasaki, T. and Kawai, T. (2014) Toll-Like Re-ceptor Signaling Pathways. Frontiers in Immunology, 5, 461. [Google Scholar] [CrossRef] [PubMed]
[35] Ramos, A., Joshi, R.S. and Szabo, G. (2022) Innate Immune Activation: Parallels in Alcohol Use Disorder and Alzheimer’s Disease. Frontiers in Molecular Neuroscience, 15, Article ID: 910298. [Google Scholar] [CrossRef] [PubMed]
[36] Pascual, M., Balino, P., Aragon, C.M., et al. (2015) Cytokines and Chemokines as Biomarkers of Ethanol-Induced Neuroinflammation and Anxiety-Related Behavior: Role of TLR4 and TLR2. Neuropharmacology, 89, 352-359. [Google Scholar] [CrossRef] [PubMed]
[37] Zamanian, J.L., Xu, L., Foo, L.C., et al. (2012) Ge-nomic Analysis of Reactive Astrogliosis. Journal of Neuroscience, 32, 6391-6410. [Google Scholar] [CrossRef
[38] Vasile, F., Dossi, E. and Rouach, N. (2017) Human Astrocytes: Structure and Functions in the Healthy Brain. Brain Structure and Function, 222, 2017-2029. [Google Scholar] [CrossRef] [PubMed]
[39] Profaci, C.P., Munji, R.N., Pulido, R.S., et al. (2020) The Blood-Brain Barrier in Health and Disease: Important Unanswered Questions. Journal of Experimental Medicine, 217, e20190062. [Google Scholar] [CrossRef] [PubMed]
[40] Haorah, J., Knipe, B., Gorantla, S., et al. (2007) Alcohol-Induced Blood-Brain Barrier Dysfunction Is Mediated via Inositol 1,4,5-Triphosphate Receptor (IP3R)-Gated Intracellular Calcium Release. Journal of Neurochemistry, 100, 324-336. [Google Scholar] [CrossRef] [PubMed]
[41] Alikunju, S., Abdul, M.P., Zhang, Y., et al. (2011) The Inflammatory Footprints of Alcohol-Induced Oxidative Damage in Neurovascular Components. Brain, Behavior, and Immunity, 25, S129-S136. [Google Scholar] [CrossRef] [PubMed]
[42] Cryan, J.F., O’riordan, K.J., Cowan, C., et al. (2019) The Mi-crobiota-Gut-Brain Axis. Physiological Reviews, 99, 1877-2013. [Google Scholar] [CrossRef] [PubMed]
[43] Milani, C., Duranti, S., Bottacini, F., et al. (2017) The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Mi-crobiota. Microbiology and Molecular Biology Reviews, 81, e00036-17. [Google Scholar] [CrossRef
[44] Khan, M.S., Ikram, M., Park, J.S., et al. (2020) Gut Microbiota, Its Role in Induction of Alzheimer’s Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins. Cells, 9, 853. [Google Scholar] [CrossRef] [PubMed]
[45] Lowe, P.P., Gyongyosi, B., Satishchandran, A., et al. (2018) Re-duced Gut Microbiome Protects from Alcohol-Induced Neuroinflammation and Alters Intestinal and Brain In-flammasome Expression. Journal of Neuroinflammation, 15, 298. [Google Scholar] [CrossRef] [PubMed]
[46] Zhang, T., Han, Y., Wang, J., et al. (2018) Comparative Ep-idemiological Investigation of Alzheimer’s Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD. Frontiers in Aging Neuroscience, 10, 176. [Google Scholar] [CrossRef] [PubMed]
[47] Hillemacher, T., Bachmann, O., Kahl, K.G., et al. (2018) Al-cohol, Microbiome, and Their Effect on Psychiatric Disorders. Progress in Neuro-Psychopharmacology & Bio-logical Psychiatry, 85, 105-115. [Google Scholar] [CrossRef] [PubMed]
[48] Gushcha, V.K., Lelevich, S.V. and Sheibak, V.M. (2019) Neurotransmitter Disturbances in Some Parts of the Rat Brain and Their Correction under Chronic and Intermittent Alcohol Intoxication. Biomeditsinskaya Khimiya, 65, 21-27. [Google Scholar] [CrossRef
[49] Shukla, P.K., Meena, A.S., Dalal, K., et al. (2021) Chronic Stress and Corticosterone Exacerbate Alcohol-Induced Tissue injury in the Gut-Liver-Brain Axis. Scientific Reports, 11, Article No. 826. [Google Scholar] [CrossRef] [PubMed]
[50] Frausto, D.M., Engen, P.A., Naqib, A., et al. (2022) Impact of Alcohol-Induced Intestinal Microbiota Dysbiosis in a Rodent Model of Alzheimer’s Disease. Frontiers in Aging, 3, Article ID: 916336. [Google Scholar] [CrossRef] [PubMed]
[51] Perriard, G., Mathias, A., Enz, L., et al. (2015) Interleukin-22 Is Increased in Multiple Sclerosis Patients and Targets Astrocytes. Journal of Neuroinflammation, 12, 119. [Google Scholar] [CrossRef] [PubMed]
[52] Adachi, Y., Moore, L.E., Bradford, B.U., et al. (1995) Anti-biotics Prevent Liver Injury in Rats Following Long-Term Exposure to Ethanol. Gastroenterology, 108, 218-224. [Google Scholar] [CrossRef] [PubMed]
[53] Crews, F.T., Lawrimore, C.J., Walter, T.J., et al. (2017) The Role of Neuroimmune Signaling in Alcoholism. Neuropharmacology, 122, 56-73. [Google Scholar] [CrossRef] [PubMed]
[54] Bjarnason, I., Peters, T.J. and Wise, R.J. (1984) The Leaky Gut of Alcoholism: Possible Route of Entry for Toxic Compounds. The Lancet, 1, 179-182. [Google Scholar] [CrossRef
[55] Chi, X., Pan, C.Q., Liu, S., et al. (2020) Regulating In-testinal Microbiota in the Prevention and Treatment of Alcohol-Related Liver Disease. Canadian Journal of Gas-troenterology and Hepatology, 2020, Article ID: 6629196. [Google Scholar] [CrossRef] [PubMed]
[56] Quigley, E. (2017) Microbiota-Brain-Gut Axis and Neurodegen-erative Diseases. Current Neurology and Neuroscience Reports, 17, 94. [Google Scholar] [CrossRef] [PubMed]
[57] Petrasek, J., Iracheta-Vellve, A., Saha, B., et al. (2015) Metabolic Danger Signals, Uric Acid and ATP, Mediate Inflammatory Cross-Talk between Hepatocytes and Immune Cells in Alcoholic Liver Disease. Journal of Leukocyte Biology, 98, 249-256. [Google Scholar] [CrossRef
[58] Shield, K.D., Parry, C. and Rehm, J. (2013) Chronic Diseases and Conditions Related to Alcohol Use. Alcohol Research, 35, 155-173.
[59] Reuter, S., Gupta, S.C., Chaturvedi, M.M., et al. (2010) Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radical Biology and Medicine, 49, 1603-1616. [Google Scholar] [CrossRef] [PubMed]
[60] Cai, Y., Xu, M.J., Koritzinsky, E.H., et al. (2017) Mitochondrial DNA-Enriched Microparticles Promote Acute-on-Chronic Alcoholic Neutrophilia and Hepatotoxicity. JCI Insight, 2, e92634. [Google Scholar] [CrossRef] [PubMed]
[61] Jo, E.K., Kim, J.K., Shin, D.M., et al. (2016) Molecular Mecha-nisms Regulating NLRP3 Inflammasome Activation. Cellular & Molecular Immunology, 13, 148-159. [Google Scholar] [CrossRef] [PubMed]
[62] Kim, A., Bellar, A., Mcmullen, M.R., et al. (2020) Functionally Di-verse Inflammatory Responses in Peripheral and Liver Monocytes in Alcohol-Associated Hepatitis. Hepatology Communications, 4, 1459-1476. [Google Scholar] [CrossRef] [PubMed]
[63] Mottaran, E., Stewart, S.F., Rolla, R., et al. (2002) Lipid Peroxidation Contributes to Immune Reactions Associated with Alcoholic Liver Disease. Free Radical Biology and Medicine, 32, 38-45. [Google Scholar] [CrossRef
[64] Wu, D. and Cederbaum, A.I. (2003) Alcohol, Oxidative Stress, and Free Radical Damage. Alcohol Research & Health, 27, 277-284.
[65] Chen, Z. and Zhong, C. (2014) Oxidative Stress in Alzheimer’s Disease. Neuroscience Bulletin, 30, 271-281. [Google Scholar] [CrossRef] [PubMed]
[66] Crews, F.T. and Nixon, K. (2009) Mechanisms of Neuro-degeneration and Regeneration in Alcoholism. Alcohol and Alcoholism, 44, 115-127. [Google Scholar] [CrossRef] [PubMed]
[67] Liu, R., Guo, X., Park, Y., et al. (2013) Alcohol Consumption, Types of Alcohol, and Parkinson’s Disease. PLOS ONE, 8, e66452. [Google Scholar] [CrossRef] [PubMed]
[68] Sánchez-Muniz, F.J., Macho-González, A., Garcimartín, A., et al. (2019) The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease. Nutrients, 11, 1558. [Google Scholar] [CrossRef] [PubMed]
[69] Venkataraman, A., Kalk, N., Sewell, G., et al. (2017) Alcohol and Alzheimer’s Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer’s Disease? Alcohol and Alcoholism, 52, 151-158. [Google Scholar] [CrossRef] [PubMed]
[70] Nutt, D., Hayes, A., Fonville, L., et al. (2021) Alcohol and the Brain. Nutrients, 13, 3938. [Google Scholar] [CrossRef] [PubMed]
[71] Thomson, A.D., Guerrini, I. and Marshall, E.J. (2012) The Evolution and Treatment of Korsakoff’s Syndrome: Out of Sight, out of Mind? Neuropsychology Review, 22, 81-92. [Google Scholar] [CrossRef] [PubMed]
[72] Oscar-Berman, M. and Marinkovic, K. (2003) Alcoholism and the Brain: An Overview. Alcohol Research & Health, 27, 125-133.
[73] Guo, R. and Ren, J. (2010) Alcohol and Acetaldehyde in Public Health: From Marvel to Menace. International Journal of Environmental Research and Public Health, 7, 1285-1301. [Google Scholar] [CrossRef] [PubMed]
[74] Nguyen, G.T., Green, E.R. and Mecsas, J. (2017) Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance. Frontiers in Cellular and Infection Microbiology, 7, 373. [Google Scholar] [CrossRef] [PubMed]